Baxter launches the ‘Choose Freedom’ campaign to educate Chronic Kidney Disease patients about Peritoneal Dialysis
Bengaluru, March 10, 2023: Baxter India Private Ltd., a global leader in dialysis care, has launched the “Choose Freedom” education campaign to raise awareness of the critical importance of timely dialysis treatment and empower End Stage Kidney Disease (ESKD) patients with an understanding of Peritoneal Dialysis (PD) therapy that helps achieve the quadruple aim of better clinical outcomes, allowing patients to maintain their lifestyle and independence, and improving health care professionals’ experiences.
Chronic Kidney Disease (CKD) is a growing epidemic and a rising global public health concern, with 850 million people affected worldwide. As a progressive disease, very often linked to diabetes, CKD can lead to kidney failure, also known as End Stage Kidney Disease (ESKD), which requires dialysis. Urgent action must be taken to address this growing health crisis and ensure those affected by the disease are empowered with the right resources to make informed decisions about treatment options.
The Choose Freedom campaign provides patients with the knowledge and confidence to have meaningful conversations about Peritoneal Dialysis and emphasises the potential positive impact of Shared Decision Making, a collaborative approach in which patients and their families work with healthcare professionals to choose the dialysis option that works best for their clinical condition, social circumstances, and lifestyle.
Dialysis is the most common form of treatment for CKD patients and involves the removal of waste and excess fluid from the blood when the kidneys are no longer able to fulfil that function well. Peritoneal Dialysis may offer several clinical, quality-of-life, and economic benefits for patients and providers. PD enables patients to maintain their lifestyle and independence while offering potentially better clinical outcomes. PD at home empowers patients to achieve their lifestyle goals and live well while on dialysis.1
Dr. Pallavi Patri, Consultant – Chief of Nephrology, Manipal Hospital, Bengaluru, said, “Chronic kidney disease (CKD) is on the rise all over the world. Timely initiation of dialysis can reduce the risk of complications and improve survival. Healthcare professionals can work closely with patients and caregivers to help them make informed decisions and empower them to play an active role in managing their health and treatment. Peritoneal Dialysis (PD) is a home-based dialysis option that provides renal patients with the flexibility they need to maintain their lifestyle and independence while offering potentially better clinical outcomes.”
Rishubh Gupta, General Manager, Baxter India Private Ltd., said, “World Kidney Day is an opportunity to draw attention to Chronic Kidney Disease as well as its management through Peritoneal Dialysis. Baxter is committed to expanding access to PD therapy and enhancing the quality of care for ESKD patients. Our goal is to make PD the initial dialysis therapy of choice by providing smarter patient-centric solutions that enable you to give your patients the best possible care for chronic kidney disease.”
Leave a Reply